scholarly article | Q13442814 |
P2093 | author name string | Anthony J | |
Rees A | |||
Pijnenborg R | |||
Vercruysse L | |||
Tiltman A | |||
Davey DA | |||
van Assche A | |||
P433 | issue | 7 | |
P304 | page(s) | 648-655 | |
P577 | publication date | 1991-07-01 | |
P1433 | published in | British Journal of Obstetrics and Gynaecology | Q27709774 |
P1476 | title | Placental bed spiral arteries in the hypertensive disorders of pregnancy | |
P478 | volume | 98 |
Q33753692 | A microfluidics assay to study invasion of human placental trophoblast cells |
Q36189562 | A prospective cohort study of the value of maternal plasma concentrations of angiogenic and anti-angiogenic factors in early pregnancy and midtrimester in the identification of patients destined to develop preeclampsia |
Q36486994 | Abnormal uterine artery remodelling in the stroke prone spontaneously hypertensive rat. |
Q41184066 | Altered Maternal Serum Matrix Metalloproteinases MMP-2, MMP-3, MMP-9, and MMP-13 in Severe Early- and Late-Onset Preeclampsia |
Q36778205 | Altered expression of norepinephrine transporter and norepinephrine in human placenta cause pre-eclampsia through regulated trophoblast invasion |
Q41839328 | Angiogenesis in the placenta: the role of reactive oxygen species signaling |
Q64234858 | Angiogenic Properties of Menstrual Stem Cells Are Impaired in Women with a History of Preeclampsia |
Q37372462 | Angiotensinogen T235 expression is elevated in decidual spiral arteries |
Q42120213 | Are intracytoplasmic sperm injection and high serum estradiol compounding risk factors for adverse obstetric outcomes in assisted reproductive technology? |
Q34461435 | Aspirin and preeclampsia prevention in patients with abnormal uterine artery blood flow |
Q37590829 | Assessment of Serum Vascular Endothelial Growth Factor Levels in Pregnancy-Induced Hypertension Patients. |
Q91966843 | Association between hypertensive pregnancy disorders and future risk of stroke in Taiwan: a Nationwide population-based retrospective case-control study |
Q35139213 | Biological functions of thyroid hormone in placenta |
Q36676660 | CXCL10/IP-10: a missing link between inflammation and anti-angiogenesis in preeclampsia? |
Q89093138 | Cardiac time intervals derived by magnetocardiography in fetuses exposed to pregnancy hypertension syndromes |
Q34996675 | Collagen type IV at the fetal-maternal interface. |
Q35747044 | Combination of PAPPA, fhCGβ, AFP, PlGF, sTNFR1, and Maternal Characteristics in Prediction of Early-onset Preeclampsia |
Q34280644 | Critical growth factors and signalling pathways controlling human trophoblast invasion |
Q34300121 | Decidual natural killer cell interactions with trophoblasts are impaired in pregnancies at increased risk of preeclampsia |
Q50043549 | Decidual regulation of trophoblast is altered in pregnancies at risk of pre-eclampsia. |
Q34182374 | Differences and similarities in the transcriptional profile of peripheral whole blood in early and late-onset preeclampsia: insights into the molecular basis of the phenotype of preeclampsiaa |
Q53071744 | Differences in uterine artery blood flow and fetal growth between the early and late onset of pregnancy-induced hypertension. |
Q33681074 | Distortion of maternal-fetal angiotensin II type 1 receptor allele transmission in pre-eclampsia. |
Q61844895 | ELABELA plasma concentrations are increased in women with late-onset preeclampsia |
Q99623638 | Early life exposure to per- and polyfluoroalkyl substances (PFAS) and latent health outcomes: A review including the placenta as a target tissue and possible driver of peri- and postnatal effects |
Q71649480 | Endothelial cell activation by tumour necrosis factor-alpha (TNF-α and the development of pre-eclampsia |
Q34372600 | Evolutionary origins of the placental expression of chromosome 19 cluster galectins and their complex dysregulation in preeclampsia |
Q58197425 | Expression of E-cadherin and its repressor Snail in placental tissue of normal, preeclamptic and HELLP pregnancies |
Q37643138 | Expression of endothelial NO synthase, inducible NO synthase, and estrogen receptors alpha and beta in placental tissue of normal, preeclamptic, and intrauterine growth-restricted pregnancies |
Q42472477 | Expression of tissue type and urokinase type plasminogen activators as well as plasminogen activator inhibitor type-1 and type-2 in human and rhesus monkey placenta. |
Q35201773 | Expression pattern and function of Notch2 in different subtypes of first trimester cytotrophoblast |
Q34280681 | Expression, regulation and functional characterization of matrix metalloproteinase-3 of human trophoblast. |
Q36026812 | Extravillous trophoblast and decidual natural killer cells: a remodelling partnership. |
Q64069869 | Failure of Decidualization and Maternal Immune Tolerance Underlies Uterovascular Resistance in Intra Uterine Growth Restriction |
Q37444801 | First-trimester maternal serum PP13 in the risk assessment for preeclampsia. |
Q36813648 | High-altitude hypoxia and preeclampsia. |
Q50090877 | Histopathological findings of pregnancy-induced hypertension: histopathology of early-onset type reflects two-stage disorder theory |
Q36489407 | How useful is uterine artery Doppler ultrasonography in predicting pre-eclampsia and intrauterine growth restriction? |
Q91719656 | Human placenta and trophoblast development: key molecular mechanisms and model systems |
Q37199588 | Human placental trophoblast invasion and differentiation: a particular focus on Wnt signaling. |
Q33926621 | Human pregnancy specific beta-1-glycoprotein 1 (PSG1) has a potential role in placental vascular morphogenesis |
Q35842147 | Human trophoblast invasion and spiral artery transformation: the role of PECAM-1 in normal pregnancy, preeclampsia, and fetal growth restriction |
Q35786771 | Human trophoblast invasion and spiral artery transformation: the role of nitric oxide |
Q91794237 | Human umbilical cord and its vessels: a histomorphometric study in difference severity of hypertensive disorders of pregnancy |
Q26746757 | Hypertensive disorders of pregnancy: what the physician needs to know |
Q33717103 | Hypoxia and the anticoagulants dalteparin and acetylsalicylic acid affect human placental amino acid transport |
Q35737097 | IFPA Award in Placentology lecture: molecular regulation of human trophoblast invasion. |
Q90093153 | Immune Cells in the Uterine Remodeling: Are They the Target of Endocrine Disrupting Chemicals? |
Q36403656 | Impaired decidual natural killer cell regulation of vascular remodelling in early human pregnancies with high uterine artery resistance |
Q37216866 | Impaired placentation in fetal alcohol syndrome |
Q37630076 | Increased angiogenic factor secretion by decidual natural killer cells from pregnancies with high uterine artery resistance alters trophoblast function. |
Q94518279 | Increased risk of maternal and neonatal complications in hormone replacement therapy cycles in frozen embryo transfer |
Q33728495 | Interdependence of JAK-STAT and MAPK signaling pathways during EGF-mediated HTR-8/SVneo cell invasion. |
Q37497808 | Internal iliac and uterine arteries Doppler ultrasound in the assessment of normotensive and chronic hypertensive pregnant women |
Q35607355 | Invasive trophoblasts stimulate vascular smooth muscle cell apoptosis by a fas ligand-dependent mechanism |
Q36107337 | Late-onset preeclampsia is associated with an imbalance of angiogenic and anti-angiogenic factors in patients with and without placental lesions consistent with maternal underperfusion |
Q36185268 | Leukocytes of pregnant women with small-for-gestational age neonates have a different phenotypic and metabolic activity from those of women with preeclampsia |
Q61845341 | Low maternal concentrations of soluble vascular endothelial growth factor receptor-2 in preeclampsia and small for gestational age |
Q33863973 | Maternal plasma concentrations of angiogenic/antiangiogenic factors in the third trimester of pregnancy to identify the patient at risk for stillbirth at or near term and severe late preeclampsia |
Q34619975 | Maternal plasma concentrations of sST2 and angiogenic/anti-angiogenic factors in preeclampsia. |
Q33909572 | Maternal plasma soluble TRAIL is decreased in preeclampsia |
Q36512063 | Maternal serum soluble CD30 is increased in normal pregnancy, but decreased in preeclampsia and small for gestational age pregnancies |
Q37051307 | Matrix metalloproteinase 9 is a distal-less 3 target-gene in placental trophoblast cells |
Q90643526 | MicroRNA-218-5p Promotes Endovascular Trophoblast Differentiation and Spiral Artery Remodeling |
Q38257810 | Models of vertical cytomegalovirus (CMV) transmission and pathogenesis |
Q38589205 | Molecular Cross-Talk at the Feto-Maternal Interface |
Q37473736 | Notch1 controls development of the extravillous trophoblast lineage in the human placenta. |
Q34080703 | Oxidative stress markers in hypertensive states of pregnancy: preterm and term disease |
Q38796954 | Pathophysiology of preeclampsia: an angiogenic imbalance and long-lasting systemic vascular dysfunction |
Q52910487 | Placental Morphology in Fetal Alcohol Spectrum Disorders. |
Q35542826 | Placental lesions associated with maternal underperfusion are more frequent in early-onset than in late-onset preeclampsia |
Q34151967 | Plasma soluble endoglin concentration in pre-eclampsia is associated with an increased impedance to flow in the maternal and fetal circulations |
Q37658758 | Platelet Count in First Trimester of Pregnancy as a Predictor of Perinatal Outcome |
Q36351625 | Preeclampsia and pregnancies with small-for-gestational age neonates have different profiles of complement split products |
Q37428029 | Preeclampsia and small-for-gestational age are associated with decreased concentrations of a factor involved in angiogenesis: soluble Tie-2. |
Q36670687 | Preeclampsia is associated with low concentrations of protein Z. |
Q93078142 | Preeclampsia: Maternal Systemic Vascular Disorder Caused by Generalized Endothelial Dysfunction Due to Placental Antiangiogenic Factors |
Q39148906 | Preeclampsia: a Cardiorenal Syndrome in Pregnancy |
Q73380136 | Preeclampsia: theories and speculations |
Q36128984 | Prepregnancy cardiovascular risk factors as predictors of pre-eclampsia: population based cohort study |
Q28075616 | Preventing deaths due to the hypertensive disorders of pregnancy |
Q28603414 | Quantifying trophoblast migration: In vitro approaches to address in vivo situations |
Q59328860 | Reduced Uteroplacental Perfusion Pressure (RUPP) causes altered trophoblast differentiation and pericyte reduction in the mouse placenta labyrinth |
Q59329268 | Regulation of Placental Extravillous Trophoblasts by the Maternal Uterine Environment |
Q33657510 | Renal markers in normal and hypertensive disorders of pregnancy in Indian women: a pilot study |
Q34234671 | Retinol binding protein 4--a novel association with early-onset preeclampsia |
Q35669266 | Role of cytokines in altitude-associated preeclampsia |
Q57169563 | Self-Renewing Trophoblast Organoids Recapitulate the Developmental Program of the Early Human Placenta |
Q37416956 | Severe preeclampsia is characterized by increased placental expression of galectin-1 |
Q39643991 | Significance of platelet endothelial cell adhesion molecule-1 (PECAM-1) and intercellular adhesion molecule-1 (ICAM-1) expressions in preeclamptic placentae |
Q47708641 | Simultaneous Ablation of Uterine Natural Killer Cells and Uterine Mast Cells in Mice Leads to Poor Vascularization and Abnormal Doppler Measurements That Compromise Fetal Well-being |
Q35038424 | Survey of calcium supplementation to prevent preeclampsia: the gap between evidence and practice in Brazil |
Q90050459 | The Impact of Infection in Pregnancy on Placental Vascular Development and Adverse Birth Outcomes |
Q34150192 | The anti-aging factor α-klotho during human pregnancy and its expression in pregnancies complicated by small-for-gestational-age neonates and/or preeclampsia |
Q34733899 | The differential expression of Kiss1, MMP9 and angiogenic regulators across the feto-maternal interface of healthy human pregnancies: implications for trophoblast invasion and vessel development |
Q34381312 | The effects of kisspeptin-54 on blood pressure in humans and plasma kisspeptin concentrations in hypertensive diseases of pregnancy |
Q61845344 | The maternal plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated in SGA and the magnitude of the increase relates to Doppler abnormalities in the maternal and fetal circulation |
Q40230103 | The pattern and magnitude of "in vivo thrombin generation" differ in women with preeclampsia and in those with SGA fetuses without preeclampsia |
Q38664824 | The prediction of late-onset preeclampsia: Results from a longitudinal proteomics study |
Q50102668 | The profiles of soluble adhesion molecules in the "great obstetrical syndromes". |
Q36205605 | The role of interleukin-1β in human trophoblast motility. |
Q37200041 | The role of placental indoleamine 2,3-dioxygenase in human pregnancy |
Q28363404 | Transforming growth factor-beta expression in human placenta and placental bed in third trimester normal pregnancy, preeclampsia, and fetal growth restriction |
Q33706415 | Unexplained fetal growth retardation: what is the cause? |
Q38459891 | Up-regulation of lymphocyte antigen 6 complex expression in side-population cells derived from a human trophoblast cell line HTR-8/SVneo |
Q37298028 | Uric acid attenuates trophoblast invasion and integration into endothelial cell monolayers |
Q37430265 | Uterine artery pulsatility index in hypertensive pregnancies: When does the index normalize in the puerperium? |
Q34098892 | Uteroplacental blood flow. The story of decidualization, menstruation, and trophoblast invasion |
Q34280658 | Wingless (Wnt)-3A induces trophoblast migration and matrix metalloproteinase-2 secretion through canonical Wnt signaling and protein kinase B/AKT activation |
Q35176633 | miR-210 targets iron-sulfur cluster scaffold homologue in human trophoblast cell lines: siderosis of interstitial trophoblasts as a novel pathology of preterm preeclampsia and small-for-gestational-age pregnancies |
Search more.